Non-small Cell Lung Cancer — Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
Citation(s)
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway